ebook Munafa Stock Market Course + Intraday & FNO calls  

Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Audentes Therapeutics (BOLD)

Technical Analysis Report for NASDAQ stock BOLD Audentes Therapeutics. Dated: 17 Nov 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock BOLD Audentes Therapeutics then click here. or read Experts views on Audentes Therapeutics or Forecast & share price targets of Audentes Therapeutics

Audentes Therapeutics Opened at 2.43 and Closed at: 2.41, which is 0% of previous session's close. It moved within a range of 2.39 and 2.44
The session was a Bearish session with an average volume of 106000, which is -29.25% of previous session's volumes.

  • Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.

A Golden cross was found 9 days back on short term averages

Support for tomorrow is 2.38 and resistance for tomorrow is 2.43
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.39, 2.36 resistance for tomorrow's hourly charts is 2.44, 2.46

10 Day SMA for Audentes Therapeutics (BOLD) is 2.44 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Audentes Therapeutics (BOLD) is 2.44 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Audentes Therapeutics (BOLD) is 2.55 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 2.61 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Audentes Therapeutics is 2 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Audentes Therapeutics is at 2.44 and 200 DMA is at 2, while 50 DMA and 100 DMA are at 2.55 and 2.61 respectively

Audentes Therapeutics (BOLD) moving average of 20 SMA is at 2.44 and 20 EMA is at 2.46

Audentes Therapeutics (BOLD) moving average of 50 SMA is at 2.55 and 50 EMA is at 2.53

Audentes Therapeutics (BOLD) moving average of 100 SMA is at 2.61 and 100 EMA is at 2.4

Audentes Therapeutics (BOLD) moving average of 200 SMA is at 2 and 200 EMA is at 2.03

Audentes Therapeutics has performed better than Zai Lab in short term. Holding Audentes Therapeutics could be a better choice for now!

Audentes Therapeutics has performed better than Veru Inc in short term. Holding Audentes Therapeutics could be a better choice for now!

Audentes Therapeutics has performed better than Urogen Pharma in short term. Holding Audentes Therapeutics could be a better choice for now!

Audentes Therapeutics has performed better than Savara Inc in short term. Holding Audentes Therapeutics could be a better choice for now!

Audentes Therapeutics has performed better than Sintx Technologies in short term. Holding Audentes Therapeutics could be a better choice for now!

Audentes Therapeutics has performed better than Pulmatrix Inc in short term. Holding Audentes Therapeutics could be a better choice for now!

Alkermes Plc has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Alkermes Plc, about 5.76% more returns!

Biomarin Pharmaceutical has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Biomarin Pharmaceutical, about 7.21% more returns!

Audentes Therapeutics has performed better than Co Diagnostics in short term. Holding Audentes Therapeutics could be a better choice for now!

Audentes Therapeutics has performed better than Crispr Therapeutics in short term. Holding Audentes Therapeutics could be a better choice for now!

Audentes Therapeutics has performed better than Cue Biopharma in short term. Holding Audentes Therapeutics could be a better choice for now!

Audentes Therapeutics has performed better than Dariohealth Corp in short term. Holding Audentes Therapeutics could be a better choice for now!

Ensign Group has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Ensign Group, about 8.54% more returns!

Hutchison China has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Hutchison China, about 1.44% more returns!

Incyte Corporation has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Incyte Corporation, about 6.25% more returns!

Kiniksa Pharmaceuticals has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Kiniksa Pharmaceuticals, about 20.57% more returns!

Myriad Genetics has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Myriad Genetics, about 0.87% more returns!

Audentes Therapeutics Technical analysis of indicators

Price action analysis of Audentes Therapeutics (BOLD) based on a short term time period is neutral. A longer time frame might give a better analysis.

ADX buy sell signal for Audentes Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Audentes Therapeutics in short term but the buy signal is initial and weak.

Audentes Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Audentes Therapeutics in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Audentes Therapeutics is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.44 and Audentes Therapeutics BOLD stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Audentes Therapeutics BOLD stock. Volume based technical analysis of Audentes Therapeutics BOLD stock is negative.

Audentes Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock BOLD Audentes Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And BOLD Experts View which covers a lot of information including buying and selling signals

BOLD future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Audentes Therapeutics or View Candle Stick Charts here

Chart Audentes Therapeutics (BOLD)  Technical (Analysis) Reports Audentes Therapeutics [

Videos related to: Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Audentes Therapeutics (BOLD)  Technical (Analysis) Reports Audentes Therapeutics [

 

Back to top